COMP <GO>
HLF vs NUS // RETURN ON INVESTED CAPITAL (ROIC)
Herbalife Ltd. (NYSE) VS. Nu Skin Enterprises Inc. (NYSE) • 15-METRIC TALLY: HLF 6
— NUS 5
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: HLF
LAST: $12.93 (-3.36%) • MKT CAP: $1.36B
roic
34.40%
LAST: $4.69 (-1.47%) • MKT CAP: $228.3M
roic
6.70%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HLF VS. NUS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HLF | NUS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 77.90% | 69.40% | +8.50 | HLF | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 34.40% | 6.70% | +27.70 | HLF | /roic <GO> |
| EV/EBITDA & P/E Valuation | 5.4x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 18.66% | 20.15% | -1.49 | NUS | /fcf-yield <GO> |
| Operating Margin | 9.50% | 4.40% | +5.10 | HLF | /operating-margins <GO> |
| Net Profit Margin | 4.50% | 10.80% | -6.30 | NUS | /net-margins <GO> |
| Revenue Growth (YoY) | 0.90% | -14.30% | +15.20 | HLF | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 5.18% | -5.18 | NUS | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.39 | 3.54 | -1.15 | NUS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | NUS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 47.5 | 43.2 | +4.36 | HLF | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 5.5x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.36B | $228.3M | $1.13B | HLF | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HLF REV | NUS REV | HLF GROSS % | NUS GROSS % | HLF FCF | NUS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.04B | $1.49B | 77.9% | 69.4% | $252.9M | $46.0M |
| FY 2024 | $4.99B | $1.73B | 77.9% | 68.2% | $163.4M | $70.2M |
| FY 2023 | $5.06B | $1.97B | — | — | $357.5M | $118.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HLF // BETA —
NUS // BETA —